chemo drugs Flashcards

(52 cards)

1
Q

common ADRs of chemo drugs

A
Nausea/Emesis
Anorexia
Alopecia 
Myelosuppression
Secondary malignancies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ways to give chemo

A

IV, oral, intravesical, intraperitoneal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

alkylating drugs

A

cyclophosphamide

cisplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

indications for cyclophosphamide

A
  • CA
  • nephrotic syndrome
  • GPA
  • SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cyclophosphamide ADRs

A
  • sterility

- hemorrhagic cystitis *evaluated very aggressively!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cisplatin ADRs

A
  • nephrotoxicity

- ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

monitoring for cisplatin

A

audiology

renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

anti-metabolites

A
  • MTX
  • 5-FU
  • cytarabine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MTX ADRs

A
  • stomatitis
  • pulmonary toxicity
  • hepatotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

reversal agents for MTX

A

leucovorin + glucarpidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MTX interactions

A
  • drugs that affect renal function (diuretics, NSAIDs, cyclosporine)
  • other antimetabolites (TMP-SMX)
  • PIs increase MTX (toxicity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5-FU ADRs

A
  • stomatitis
  • enterocolitis
  • hyperpigmentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cytarabine ADRs

A

cytarabine syndrome

cerebellar toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cytarabine syndrome characteristics & when it occurs

A

fever, bone pain, chest pain, MP rash, myalgia, malaise, conjunctivitis
occurs 6-12 hours following administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do you manage cytarabine syndrome

A

corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

chemo antibiotics

A
  • doxorubicin

- bleomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

doxorubicin baseline monitoring

A

cardiac eval via ECG, MUGA +/- ECHO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

doxorubicin ADR

A

cardiotoxicity

radiation recall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

who is doxorubicin contraindicated in

A

if LVEF is <30-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

when can doxorubicin cardiotoxicity present

A

may be delayed for 7-8 years after tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is radiation recall

A
  • occurs with doxorubicin in pts who have had prior XRT

- warmth, erythema, dermatitis at prior radiation port –> severe desquamation/ulceration

22
Q

when does radiation recall occur

A

5-7 days after administration of doxorubicin

23
Q

bleomycin ADRs

A
  • rash, striae, induration, hyperkeratosis, vesiculation, peeling = most common on palmar/plantar surfaces
  • acute/chronic interstitial pneumonitis > pulmonary fibrosis
24
Q

major thing to monitor with Bleomycin

25
plant alkaloids
- vinblastine | - paclitaxel
26
ADRs of vinblastine
- SIADH - hyperuricemia - myelosuppression
27
ADRs of paclitaxel
- peripheral neuropathy - hypersensitivity rxn - myelosuppression - arthralgia/myalgia - rhythm abnormalities
28
what should you monitor with paclitaxel
hypersensitivity rxn
29
what drugs help improve delayed CINV
substance P/NK inhibitors (-pitant)
30
what drugs help improve acute CINV
serotonin antagonists (-setron)
31
what serotonin agonist is only approved for CINV
palonosetron (2nd gen)
32
what is important to remember with serotonin antagonists for CINV
SCHEDULE THEM!
33
ADRs of serotonin antagonists
- QTc prolongation | - HA
34
dexamethasone's role in CINV
helps with acute and delayed CINV | for highly emetogenic agents
35
marijuana CINV drugs
dronabinol | nabilone
36
dronabinol schedule
III
37
nabilone schedule
II
38
indication for dronabinol & nabilone
tx of CINV that hasn't responded to other agents
39
EPO stimulating agents (ESAs)
- epoetin alfa - darbepoetin alfa - peginesatide
40
indications for ESAs
anemia in CKD, AZT-tx HIV pts, chemotherapy cancer pts
41
ESA monitoring
- hgb - BP - transferrin saturation - CBC, BUN, K
42
3 big ADR/precautions for ESA
1. ckd pts 2. cancer pts 3. major surgery
43
what is the big deal with giving ESA to CKD pts
more deaths, more HTN, CHF, progression to HD
44
how to prevent ADRs of ESA in CKD pts
keep hgb between 10-12, do not exceed 13
45
what is the big deal with higher Hgb in cancer pts
shortened survival, time-to-tumor progression, more thromboembolic events if target hgb was >/= 12
46
how to prevent ADRs of ESAs in cancer pts
prescribing and access restrictions to give ESAs to cancer pts (APPRISE oncology program)
47
what is the big deal with ESAs in surgery pts
associated with increase DVT after orthopedic surgery
48
how to prevent ADRs of ESAs in orthosurg pts
limit dosing to maintain the lowest HgB level needed to avoid transfusions
49
granulocyte-colony stimulating factor
Filgastrim | Pegfilgastrim
50
granulocyte-macrophage colony stimulating factor
sargramostim
51
indications for CSFs
cancer pts receiving myelosuppressive chemo | cancer pts receiving bone marrow transplant
52
ADRs of CSFs
- fever - rash/petechiae - splenomegaly - bone pain - myeloid leukemia